Related Experiment Video
Updated: May 21, 2026

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
Therapeutic interventions targeting Beta amyloid pathogenesis in an aging dog model
Sarah B Martin1, Amy L S Dowling, Elizabeth Head
1Sanders Brown Center on Aging, University of Kentucky, Lexington KY, USA.
Aging dogs exhibit Alzheimer
Area of Science:
- Comparative medicine
- Neuroscience
- Aging research
Background:
- Aged dogs share cognitive and pathological aging responses with humans.
- Canine models develop beta-amyloid (Aβ) plaques, similar to Alzheimer's Disease (AD).
- These plaques correlate with cognitive impairments in aged dogs.
Purpose of the Study:
- To review canine cognition and neuropathology in aging.
- To assess the utility of the aging canine model for AD therapy research.
- To understand the safety and efficacy of Aβ-targeted AD prevention.
Main Methods:
- Literature review of canine aging studies.
- Analysis of neuropathological findings in dogs.
- Evaluation of therapeutic strategies targeting Aβ.
Main Results:
- The aging canine model recapitulates key aspects of human AD.
- Canine studies provide insights into Aβ production, aggregation, and clearance.
- This model aids in evaluating potential AD interventions.
Conclusions:
- The aging canine model is valuable for AD research.
- It facilitates understanding of Aβ-related cognitive decline.
- It aids in developing and testing novel AD therapies.
More Related Videos
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer Disease ll: Pathophysiology